Transparent Thinking.
Fifteen years of working notes from inside clinical trial transparency — TrialAssure resources on regulation changes, registry snapshots, case studies, and the honest state of AI in regulated writing.
What you will find here
Insights from inside clinical trial transparency, published continuously since 2012 — not a content program built to rank. The blog is the running commentary, including the per-registry Registry Snapshot series; whitepapers and guides are the deep dives; webinars and events are the live sessions and their recordings; news is announcements and press. If you are trying to answer a specific regulatory question rather than read, the solutions pages are faster.
Latest
View the blog →
FDA’s Transparency Roadmap: What It Means for Clinical Trial Disclosure
What AI Drug Discovery Can Teach Us About Responsible AI Across the Clinical Development Pipeline
Helping Medical Writers Embrace AI Through Effective Change Management
FDA Flags Thousands of Missing Clinical Trial Results. Is Your Team Prepared?
Experts Share Real-World Lessons to Applying AI in Medical Writing
How TrialAssure is Building Better DSURs with Purpose-Built Prompts, Smarter Sources, and a Proven Approach
Prefer answers to reading?
Get a demo
Trusted by 8 of the top 10 clinical development companies